摘要
近年来,嵌合抗原受体T细胞免疫疗法已逐步成为针对肿瘤治疗的研究热点。在对627项CAR-T技术专利进行系统研究的基础上,通过分析该领域的专利申请状况,提出了当前该技术的发展态势;通过分析判断该项专利技术的市场应用阶段及前景,研究提出了我国在该领域应重点突破的关键技术以及技术创新方向。
In recent years, chimeric antigen receptor T-cell (CAR-T) immunotherapy has gradually become a research hotspot for tumor therapy. Based on the systematic research on 627 CAR-T technology patents, the current development trend of the technology is proposed by analyzing the status of patent applications in this field. The market application stage and prospect of the patent technology are analyzed and judged. Key technologies and technological innovations that China should focus on in this field are put forward.
作者
李晨
LI Chen(Medical and Biological Inventions Review Department of Patent Office,CNIPA,Beijing 100088,China)
出处
《天津科技》
2019年第5期58-60,共3页
Tianjin Science & Technology
关键词
嵌合抗原受体T细胞
专利申请
专利分析
chimeric antigen receptor T-cell (CAR-T)
patent application
patent analysis